Web Summary
Q1: What is the physical address of Penlon Ltd.'s global headquarters?
A1: The global headquarters of Penlon Ltd. is located at Abingdon Science Park, Barton Lane, Abingdon OX14 3NB, United Kingdom.
Q2: What products does Penlon offer in the anaesthesia and medical equipment sector?
A2: Penlon offers a range of products including airway management, anaesthesia machines (such as Prima 460, Prima 451 MRI, and Prima 465), endoscopy systems, infusion systems, MRI products, oxygen therapy devices, patient monitors, suction control systems, and Vedkang endoscopic accessories.
Q3: In which industry is Penlon primarily involved?
A3: Penlon is primarily involved in the medical equipment sector, specifically in anaesthesia and related medical technologies.
Q4: What services does Penlon provide to its customers?
A4: While the provided text does not explicitly state all of Penlon's services, it mentions that they offer support for their products, including technical support, service training, and general enquiry services. Additionally, they have a contact form on their website where customers can send messages.
Q5: How can one get in touch with Penlon Ltd.'s customer support team?
A5: Customers can reach out to Penlon's global headquarters by calling +44 (0) 1235 547000 or emailing info@penlon.com. They also have a contact form on their website where customers can send messages.
Q6: What is the name of Penlon's latest high-end anaesthetic machine?
A6: The Prima 465 is the latest high-end anaesthetic machine from Penlon, providing the ideal solution for today’s busy operating room.
Q7: In which medical trade fairs and exhibitions will Penlon be exhibiting in 2024?
A7: Penlon will be exhibiting at Arab Health 2025, MEDICA 2024, EBME Expo 2024, FIME 2024, Euroanaesthesia 2024, Hospitalar 2024, and other events as mentioned in the news archive section of their website.
Q8: What is the name of Penlon's endoscopic accessories range expansion?
A8: Penlon has expanded its Vedkang endoscopic accessories range available to UK clinicians.